| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008776940 |
| P356 | DOI | 10.1186/S12920-016-0182-9 |
| P8608 | Fatcat ID | release_32jk4dogj5cdhfpjtuwzg56wpe |
| P932 | PMC publication ID | 4851803 |
| P698 | PubMed publication ID | 27129388 |
| P5875 | ResearchGate publication ID | 301733555 |
| P50 | author | Jong Bhak | Q22973876 |
| P2093 | author name string | Sunghoon Park | |
| Kyudong Han | |||
| Hee Jae Joo | |||
| Sunshin Kim | |||
| Hongliang Chen | |||
| Byung Chul Kim | |||
| HeeJung Jung | |||
| Hwanjong Kwak | |||
| Hyungsik Chu | |||
| JeongSub Kwon | |||
| Min Gyun Kim | |||
| SeungJae Lee | |||
| Sung Hee Han | |||
| P2860 | cites work | Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. | Q39024055 |
| Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. | Q40028555 | ||
| Screening advances and diagnostic choice: the problem of residual risk | Q44592486 | ||
| Size distributions of maternal and fetal DNA in maternal plasma. | Q47432593 | ||
| Impact of introducing a national policy for prenatal Down syndrome screening on the diagnostic invasive procedure rate in England | Q50110415 | ||
| Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. | Q51349861 | ||
| Comparison of the performance of Ion Torrent chips in noninvasive prenatal trisomy detection. | Q51514162 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| No evidence of fetal DNA persistence in maternal plasma after pregnancy | Q58008264 | ||
| Chromosome-selective sequencing of maternal plasma cell–free DNA for first-trimester detection of trisomy 21 and trisomy 18 | Q61847821 | ||
| Risk assessment of amniocentesis between 11 and 15 weeks: comparison to later amniocentesis controls | Q71683023 | ||
| Chorionic villus sampling by biopsy forceps. Results of 1580 procedures from a single centre | Q71708255 | ||
| Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting | Q83395075 | ||
| Maternal source of false-positive fetal sex chromosome aneuploidy in noninvasive prenatal testing | Q86493660 | ||
| Ultrafast and memory-efficient alignment of short DNA sequences to the human genome | Q21183894 | ||
| A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers | Q21266698 | ||
| Update on Procedure-Related Risks for Prenatal Diagnosis Techniques | Q22241937 | ||
| ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal Abnormalities | Q22242787 | ||
| DNA Sequencing versus Standard Prenatal Aneuploidy Screening | Q22250872 | ||
| Fast and accurate short read alignment with Burrows-Wheeler transform | Q24653853 | ||
| Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center | Q27007785 | ||
| SOAP2: an improved ultrafast tool for short read alignment | Q28247469 | ||
| Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing | Q33665399 | ||
| DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study | Q34029044 | ||
| Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma | Q34336915 | ||
| The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform | Q34374066 | ||
| Rapid clearance of fetal DNA from maternal plasma | Q34388637 | ||
| Feasibility study of semiconductor sequencing for noninvasive prenatal detection of fetal aneuploidy | Q34567793 | ||
| Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing | Q35032051 | ||
| Performance comparison between rapid sequencing platforms for ultra-low coverage sequencing strategy | Q35126522 | ||
| The new sequencer on the block: comparison of Life Technology's Proton sequencer to an Illumina HiSeq for whole-exome sequencing | Q36042292 | ||
| Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population | Q37089135 | ||
| Screening for fetal aneuploidies at 11 to 13 weeks | Q37826399 | ||
| Non-invasive prenatal testing for aneuploidy: current status and future prospects | Q38114375 | ||
| P433 | issue | 1 | |
| P921 | main subject | semiconductor | Q11456 |
| Down syndrome | Q47715 | ||
| P304 | page(s) | 22 | |
| P577 | publication date | 2016-04-30 | |
| P1433 | published in | BMC Medical Genomics | Q15754662 |
| P1476 | title | Comparison of two high-throughput semiconductor chip sequencing platforms in noninvasive prenatal testing for Down syndrome in early pregnancy | |
| P478 | volume | 9 |
| Q30234867 | Analysis of Cell-Free DNA in Maternal Blood in Screening For Aneuploidies: Updated Meta-Analysis. |
| Q47308150 | Cost-effective and accurate method of measuring fetal fraction using SNP imputation |
| Q47618331 | Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. |
| Q90259969 | Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing |
Search more.